Biomedical Cluster - Skolkovo Community

- All site RSS

Cluster News

Skolkovo and AstraZeneca accelerator finalists present their developments
The final phase of the corporate acceleration program that has been co-run by Skolkovo Foundation and international biopharmaceutical company AstraZeneca is now complete The representatives of six corporate...
30.12.2019, Статьи

Insilico Medicine nabs $200 million AI-powered drug discovery deal
Creators of a new machine-learning drug discovery platform Insilico Medicine has inked a dual-program drug discovery deal with Jiangsu Chia Tai Fenghai Pharmaceutical (CTFH) worth up to $200 million. Insilico...
18.10.2019, Пресса о нас

Startup Hitches Ride on ISS to Make Space Meat
In the world of artificial meats, you can’t get more alien than growing your beef in space. Cosmonaut Oleg Kononenko holds a 3D Bioprinting Solutions printer aboard the ISS.Source: 3D Bioprinting...
07.10.2019, Пресса о нас

National Leg of EWC Competition
Residents of Skolkovo Foundation – Group-IB, Motorika, DRD and HemaCore will take part in the final leg of the Entrepreneurship World Cup (EWC), a competition of young entrepreneurs from across the...
30.07.2019, Фотогалерея

Axbio Inc. developed a new technology for genetic sequencing
28/06/2019 Axbio Inc. developed a new technology for genetic sequencing, significantly ahead of the available analogues in such key parameters as price, accuracy and reading speed On June 28, 2019, AxBio...
28.06.2019, Новости кластера Биомед

Senior management of largest Taiwanese companies visit Skolkovo
A large group of managers of major technology companies from Taiwan visited the Skolkovo Foundation. The delegation, led by James Huang, Chairman of the Taiwan Council for the Development of Foreign Trade...
25.06.2019, Статьи

Skolkovo at BIO at Cellicon Valley
PHILADELPHIA BIO, the flagship annual event in biomedicine and biotechnologies takes place in the Cellicon Valley on June 3–6 this year. The new name - Cellicon Valley - has not yet established itself...
03.06.2019, Статьи

The First Russian Targeted Therapy Drug Developed with the Support of Skolkovo Foundation Has Entered the Clinical Trial Stage in Oncology
The First Russian Targeted Therapy Drug Developed with the Support of Skolkovo Foundation Has Entered the Clinical Trial Stage in Oncology The Ministry of Healthcare of the Russian Federation has approved...
29.05.2019, Статьи

Long-lived roundworms helped identify new anti-aging compounds among the FDA approved drugs
Researchers from Gero, Skolkovo Institute of Science and Technology (Skoltech), Moscow Institute of Physics and Technology (MIPT), and University of Arkansas for Medical Sciences (UAMS) collaborated to...
22.05.2019, Статьи

Skolkovo and AstraZeneca Launch Startup Challenge 2019 Accelerator
The Skolkovo Foundation and AstraZeneca, an international biopharmaceutical company, have announced the launch of a new accelerator for projects in the fields of oncology, cardiovascular diseases, metabolism...
06.05.2019, Новости

Beeline and Motorika Win GSMA Global Mobile Awards 2019 in Barcelona
The joint project of Beeline and Motorika, a participant of the Skolkovo Foundation, on remote monitoring of high-tech assistive devices, has won in the nomination for “Best Use of Mobile for Accessibility...
27.02.2019, Новости

Aging and chronic diseases share genetic factors, study reveals
Aging doubles your risks of chronic diseases every 8 years and there are genes responsible for that The global population aged 60 or over is growing faster than all younger age groups and faces the tide...
30.01.2019, Пресса о нас

Skolkovo resident becomes first company to print live tissue in space
Skolkovo resident company 3D Bioprinting Solutions has become the first company to use a 3D printer to create live tissue in space, printing an organ construct for the thyroid gland of a mouse on board...
13.12.2018, Статьи

Skolkovo startups present biomed solutions in Cambridge
Five Russian startups – the winners of the Startup Challenge accelerator organised jointly by the Skolkovo Foundation and multinational pharma giant AstraZeneca – are showcasing their inventions...
04.12.2018, Новости

MENTOR: Alexy Khrabrov
Country, city: USA, San Francisco. Visiting Russia once or twice a year. Job title, company: By the Bay, Founder The main milestones: PhD in Computer Science from UPenn, first CS PhD on influence on Twitter...
29.11.2018, Анкеты Менторов